Rampertab Shameze's Net Worth
$153 Thousand
Who is Rampertab Shameze?
Rampertab Shameze does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Zomedica Pharmaceuticals Corp., and ASENSUS SURGICAL, INC..
SEC CIK
Rampertab Shameze's CIK is 0001721810
Past Insider Trading and Trends
2022 was Rampertab Shameze's most active year for acquiring shares with 6 total transactions. Rampertab Shameze's most active month to acquire stocks was the month of January. 2024 was Rampertab Shameze's most active year for disposing of shares, totalling 15 transactions. Rampertab Shameze's most active month to dispose stocks was the month of January. 2018 saw Rampertab Shameze paying a total of $60,000.00 for 300,000 shares, this is the most they've acquired in one year. In 2023 Rampertab Shameze cashed out on 376,151 shares for a total of $81,555.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zomedica Pharmaceuticals Corp. (ZOM) Snapshot price: $0.1264
Interim CEO and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
| +107.32% | 176K |
$0.20 | $35,200.00 | 340K |
Mar 12
| |||
Form 4
| +310.00% | 124K |
$0.20 | $24,800.00 | 164K |
Jan 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ASENSUS SURGICAL, INC. (ASXC) No price found
EVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -595.37K |
—
|
—
|
0
|
Aug 22
| |||
Form 4
| +10.01% | 37.88K |
$0.25 | -$10,909.50 | 416.29K |
Apr 21
| |||
Form 4
| +52.67% | 130.54K |
$0.27 | -$40,599.09 | 378.4K |
Feb 4 - Feb 6
| |||
Form 4
| +4.07% | 9.69K |
$0.51 | -$3,557.25 | 247.86K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
| +154.30% | 144.51K |
$0.75 | -$77,998.50 | 238.17K |
Feb 3 - Feb 4
| |||
Form 4
| +11.49% | 9.65K |
$0.38 | -$2,665.70 | 93.66K |
Jul 1
| |||
Form 4
| +593.75% | 71.9K |
$0.80 | -$21,368.80 | 84.01K |
Feb 4
| |||
Form 4
|
∞
| 12.11K |
$2.93 | -$13,354.94 | 12.11K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||